The importance of natural IgM antibodies in protection against infections is still emerging and these antibodies have a potential role in the maintenance of homeostasis through clearance of apoptotic bodies, complement-dependent mechanisms, inflammation and exclusion of misfolded proteins. Natural IgM act as a first line of defence against unknown hazardous factors and are present in most vertebrates. We investigated the functional capacity of anti-HIV-1 IgM monoclonal antibodies, from a combinatorial Fab library derived from healthy individuals, and evaluated their protective role in inhibiting HIV-1 in vitro when passing across the human mucosal epithelial barrier. Primary HIV-1 isolates were efficiently transmitted over the tight polariz...
Immunoglobulins (Ig) of pooled healthy human sera were purified by affinity chromatography based on ...
Mucosal sites serve as the principle venues through which primary human immunode®ciency virus type 1...
OBJECTIVE: Although passive immunization with anti-HIV-1 Env IgG1 neutralizing monoclonal antibodies...
The importance of natural IgM antibodies in protection against infections is still emerging and thes...
During the last years a few populations who remain uninfected despite repeated HIV-1 viral exposures...
International audienceAIDS is mainly a sexually transmitted disease, and accordingly, mucosal tissue...
HIV infection not only destroys CD4+ T cells but also inflicts serious damage to the B-cell compartm...
Sexual transmission of the Human Immunodeficiency Virus Type 1 (HIV-1) accounts for the majority of ...
Prevention of the initial infection of mucosal dendritic cells (DC) and interruption of the subseque...
Both IgG and secretory IgA Abs in mucosal secretions have been implicated in blocking the earliest e...
HIV-1-specific IgA has been described in the genital tract and plasma of HIV-1 highly exposed, persi...
Definition of the key parameters mediating effective antibody blocking of HIV-1 acquisition within m...
HIV vaccine efforts tend to focus on the induction of IgG neutralizing antibodies. In part, this may...
International audienceBroadly neutralizing antibodies (bNAbs) offer promising opportunities for prev...
AbstractWe show that intraepithelial cell neutralization of HIV by IgA antibodies to internal viral ...
Immunoglobulins (Ig) of pooled healthy human sera were purified by affinity chromatography based on ...
Mucosal sites serve as the principle venues through which primary human immunode®ciency virus type 1...
OBJECTIVE: Although passive immunization with anti-HIV-1 Env IgG1 neutralizing monoclonal antibodies...
The importance of natural IgM antibodies in protection against infections is still emerging and thes...
During the last years a few populations who remain uninfected despite repeated HIV-1 viral exposures...
International audienceAIDS is mainly a sexually transmitted disease, and accordingly, mucosal tissue...
HIV infection not only destroys CD4+ T cells but also inflicts serious damage to the B-cell compartm...
Sexual transmission of the Human Immunodeficiency Virus Type 1 (HIV-1) accounts for the majority of ...
Prevention of the initial infection of mucosal dendritic cells (DC) and interruption of the subseque...
Both IgG and secretory IgA Abs in mucosal secretions have been implicated in blocking the earliest e...
HIV-1-specific IgA has been described in the genital tract and plasma of HIV-1 highly exposed, persi...
Definition of the key parameters mediating effective antibody blocking of HIV-1 acquisition within m...
HIV vaccine efforts tend to focus on the induction of IgG neutralizing antibodies. In part, this may...
International audienceBroadly neutralizing antibodies (bNAbs) offer promising opportunities for prev...
AbstractWe show that intraepithelial cell neutralization of HIV by IgA antibodies to internal viral ...
Immunoglobulins (Ig) of pooled healthy human sera were purified by affinity chromatography based on ...
Mucosal sites serve as the principle venues through which primary human immunode®ciency virus type 1...
OBJECTIVE: Although passive immunization with anti-HIV-1 Env IgG1 neutralizing monoclonal antibodies...